Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    8813038 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed A Randomized, Double-Blind Phase II/III Trial of Monotherapy vs. Combination Therapy With Nucleoside Analogs in HIV-Infected Persons With CD4 Cells of 200-500/mm3
Condition: HIV Infections
Interventions: Drug: Zidovudine;   Drug: Zalcitabine;   Drug: Didanosine

Indicates status has not been verified in more than two years